Agilent doubles down on oligonucleotides | Chemical & Engineering News
Volume 94 Issue 33 | p. 16 | Concentrates
Issue Date: August 22, 2016 | Web Date: August 21, 2016

Agilent doubles down on oligonucleotides

Department: Business
Keywords: pharmaceutical chemicals, oligonucleotides, instrumentation, jobs

Agilent Technologies plans to at least double its oligonucleotide manufacturing capacity with an expansion of its plant in Frederick, Colo. The project is expected to create between 150 and 200 jobs. The instrumentation firm began its foray into nucleic acids in 2006 with the acquisition of SynPro. In 2008, it purchased Dow Chemical’s oligonucleotides business and moved it from Michigan to Colorado.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment